Spotlight on UV safety, pigmentary disorders, and emerging AD therapies-plus upcoming savings you won't want to miss.
July 2025
As we step into summer's peak, July offers an ideal moment to raise awareness around two critical dermatologic concerns:
With skin cancer rates continuing to rise across the U.S., dermatology professionals play a critical role in promoting sun safety. Use these summer months to reinforce best practices around sunscreen use, year-round UV protection, and early skin cancer detection.
Pigmentary disorders like melasma and post-inflammatory hyperpigmentation remain among the most persistent-and emotionally challenging-conditions in dermatology. Take this month to discuss common triggers, reinforce treatment adherence, and highlight new and emerging therapies suitable for all skin types.
Keep an eye on your inboxes for exclusive savings on SBS and MOPD 2026. You won't want to miss these limited-time offers.
Discover how a new class of biologics targeting the OX40/OX40L pathway is reshaping the treatment landscape for atopic dermatitis. In this new on-demand CME with experts Christopher G. Bunick, MD, PhD, and Emma Guttman-Yassky, MD, PhD, explore data from early-phase trials showing durable improvements and strong safety profiles. Plus, gain insight into how these agents may offer longer-term relief by addressing disease mechanisms upstream.
Stay inspired and in the know-connect with us for the latest updates, expert tips, and exclusive offers!
This is an educational message from LiVDerm. 1801 N. Military Trail, Suite 110 • Boca Raton, FL 33431, United States •561-893-8625 You are subscribed to this newsletter with the email address %user_email%. To unsubscribe click here.
